Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: the atherosclerosis risk in communities study.
Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: the atherosclerosis risk in communities study.
复制标题
DOI:
10.1161/strokeaha.114.005243
复制
发表时间:
2014-09
期刊:
影响因子:
8.3
通讯作者:
Alonso A
中科院分区:
文献类型:
--
作者:
Chen LY;Lopez FL;Gottesman RF;Huxley RR;Agarwal SK;Loehr L;Mosley T;Alonso A
The mechanism underlying the association of atrial fibrillation (AF) with cognitive decline in stroke-free individuals is unclear. We examined the association of incident AF with cognitive decline in stroke-free individuals, stratified by subclinical cerebral infarcts (SCIs) on brain MRI scans. We analyzed data from 935 stroke-free participants (mean age±SD, 61.5±4.3 years; 62% women; and 51% black) from 1993–1995 through 2004–2006 in the Atherosclerosis Risk in Communities Study, a biracial community-based prospective cohort study. Cognitive testing (including the Digit Symbol Substitution [DSS] and the Word Fluency [WF] test) was performed in 1993–1995, 1996–1998, and 2004–2006, and brain MRI scans in 1993–1995 and 2004–2006. During follow-up, there were 48 incident AF events. Incident AF was associated with greater annual average rate of decline in DSS (−0.77; 95% CI, −1.55 to 0.01; P=0.054) and WF (−0.80; 95% CI, −1.60 to −0.01; P=0.048). Among participants without SCIs on brain MRI scans, incident AF was not associated with cognitive decline. In contrast, incident AF was associated with greater annual average rate of decline in WF (−2.65; 95% CI, −4.26 to −1.03; P=0.002) among participants with prevalent SCIs in 1993–1995. Among participants who developed SCIs during follow-up, incident AF was associated with a greater annual average rate of decline in DSS (−1.51; 95% CI, −3.02 to −0.01; P=0.049). The association of incident AF with cognitive decline in stroke-free individuals can be explained by the presence or development of SCIs, raising the possibility of anticoagulation as a strategy to prevent cognitive decline in AF.